Translated by

Microsoft Intelligent Network for Eyecare




2016: Creation

On December 19, 2016 the Microsoft company announced creation of consortium MINE (Microsoft Intelligent Network for Eyecare) which purpose is development and deployment of artificial intelligence technologies for treatment and diagnosis of diseases of eyes. The union created with assistance of the Indian Eye institute of L.V. LV Prasad Eye Institute will include business companies and non-profit organizations, large research and educational institutions, such as University of Rochester (USA) and Federal University of São Paulo (Brazil).

Participants of MINE will collect and process jointly information on diseases of eyes. In particular, it is going to pay close attention to the speed of development of short-sightedness in children, conditions influencing deterioration in children's sight and also forecasting of results of transactions for visual bodies and the choice of optimal individual solutions in refraction surgery.

Microsoft uses artificial intelligence for treatment of eye diseases
Microsoft uses artificial intelligence for treatment of eye diseases

The project started in India where by the end of 2016 about 55 million people having different deviations in functioning of a visual system live. In the world of such people there are about 285 million.

As the organizer of consortium Microsoft will provide to partners a cloud platform of Cortana Intelligence Suite for creation of advanced analytical tools and models of artificial intelligence for treatment and diagnosis of eye diseases.

Besides, Microsoft began to use in India service of machine learning Azure Machine Learning and a set of an e-business intelligence Power BI for studying of cases of diseases of an eye and drawing up forecasts before surgeries. The received results help doctors to calculate approximate time during which diseases of patients can progress, allowing to build the most optimal plans of treatment. Only in India software of Microsoft processes medical records more than 1.1 million patients.[1]